Related Experiment Video
Updated: Apr 7, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
Binding of SGTA to Rpn13 selectively modulates protein quality control
Pawel Leznicki1, Jelena Korac-Prlic2, Katarzyna Kliza3
1Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Abstract:
Rpn13 is an intrinsic ubiquitin receptor of the 26S proteasome regulatory subunit that facilitates substrate capture prior to degradation. Here we show that the C-terminal region of Rpn13 binds to the tetratricopeptide repeat (TPR) domain of SGTA, a cytosolic factor implicated in the quality control of mislocalised membrane proteins (MLPs). The overexpression of SGTA results in a substantial increase in steady-state MLP levels, consistent with an effect on proteasomal degradation. However, this effect is strongly dependent upon the interaction of SGTA with the proteasomal component Rpn13. Hence, overexpression of the SGTA-binding region of Rpn13 or point mutations within the SGTA TPR domain both inhibit SGTA binding to the proteasome and substantially reduce MLP levels. These findings suggest that SGTA can regulate the access of MLPs to the proteolytic core of the proteasome, implying that a protein quality control cycle that involves SGTA and the BAG6 complex can operate at the 19S regulatory particle. We speculate that the binding of SGTA to Rpn13 enables specific polypeptides to escape proteasomal degradation and/or selectively modulates substrate degradation.
Insights
The cytosolic factor SGTA binds Rpn13, a proteasome component, to regulate the degradation of mislocalized membrane proteins (MLPs). This interaction is crucial for controlling MLP levels via the 26S proteasome.
Area of Science:
- Cell Biology
- Protein Degradation
- Molecular Mechanisms
Background:
- Rpn13 is a ubiquitin receptor in the 26S proteasome, essential for substrate capture.
- SGTA is a cytosolic factor involved in the quality control of mislocalized membrane proteins (MLPs).
Purpose of the Study:
- To investigate the interaction between Rpn13 and SGTA.
- To elucidate the role of SGTA-Rpn13 interaction in regulating MLP proteasomal degradation.
Main Methods:
- Co-immunoprecipitation assays to confirm protein-protein interactions.
- Analysis of steady-state MLP levels upon overexpression of SGTA or Rpn13 mutants.
- Site-directed mutagenesis to disrupt the SGTA-Rpn13 binding interface.
Main Results:
- The C-terminal region of Rpn13 directly binds to the tetratricopeptide repeat (TPR) domain of SGTA.
- Overexpression of SGTA increases steady-state MLP levels, dependent on Rpn13 interaction.
- Disruption of SGTA-Rpn13 binding via Rpn13 mutants or SGTA mutations reduces MLP levels.
Conclusions:
- SGTA regulates MLP access to the 26S proteasome through its interaction with Rpn13.
- A protein quality control pathway involving SGTA and the BAG6 complex operates at the 19S proteasome regulatory particle.
- SGTA-Rpn13 binding may modulate substrate degradation, potentially allowing escape from proteasomal degradation.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Protein Folding Quality Check in the RER
Translational Regulation
Regulation of Expression at Multiple Steps
Directing Proteins to the Rough Endoplasmic Reticulum
Tail-anchoring of Proteins in the ER Membrane

